Natrixam 1.5mg/5mg Modified-Release Tablets
Natrixam 1.5mg/5mg is a fixed-dose combination medication primarily used for the treatment of essential hypertension (high blood pressure). It is typically prescribed as a "substitution therapy" for patients who are already successfully managing their blood pressure using Indapamide (1.5mg) and Amlodipine (5mg) as separate tablets.
How Natrixam 1.5mg/5mg Works
This medication combines two active ingredients that work together to lower blood pressure:
- Indapamide (1.5mg): A thiazide-like diuretic (water pill) that helps the kidneys remove excess salt and water, reducing the volume of blood.
- Amlodipine (5mg): A calcium channel blocker that relaxes and widens the blood vessels, allowing blood to flow more easily.
By using both mechanisms, Natrixam provides a simplified daily routine for maintaining healthy cardiovascular health.
Understanding the "Sachet" Labeling in Nigeria
In the Nigerian pharmaceutical market, you may see Natrixam listed "per sachet." It is important to understand that Natrixam is a modified-release tablet, not a powder. The term "sachet" is a local colloquialism used to describe a single blister strip (usually containing 5 or 10 tablets) sold individually from a full box.
Dosage and Administration
Natrixam should be taken exactly as prescribed by your doctor.
- Standard Dosage: Usually one tablet daily, preferably in the morning.
- How to take: Swallow the tablet whole with water. Do not crush or chew it, as this can interfere with the modified-release mechanism.
- If you miss a dose: Do not double your dose; simply take the next one at the scheduled time.
Potential Side Effects
While effective, some users may experience side effects such as:
- Dizziness or headache
- Ankle swelling (oedema)
- Fatigue or sleepiness
- Palpitations
If you experience any severe allergic reactions or persistent discomfort, seek medical attention immediately.
For more information or to discuss your prescription, you can speak with a GoMed pharmacist today for professional guidance.